← Leaderboards
Mark Newman
Geovax, Inc.
$299,927
Attributed
$299,927
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,927 · 1
By mechanism
R43$299,927 · 1
Top collaborators
No co-investigators on record.
Most similar at Geovax, Inc.
Same institution · by research overlap
- Robert T McNally$7,369,398
- Farshad Guirakhoo$899,820
- Jennifer L Nelms$1,303,014
- Sue Fen Kwa$276,690
- Harriet Robinson$199,442
Others in their field
Other Emerging Leaders on “Ace2”
- Hongpeng Jia · Johns Hopkins University$3,826,476
- Ya-Wen Chen · University Of Southern California$3,181,082
- Yogesh K Gupta · University Of Texas Hlth Science Center$3,161,127
- Aaron Gregory Schmidt · Boston Children'S Hospital$2,740,403
- Megan A O'Connor · University Of Washington$2,375,036
- Ricardo Rajsbaum · University Of Texas Med Br Galveston$2,360,403
Research focus
Ace2Animal ModelAnimalsAntibodiesAntibody-Dependent Cell CytotoxicityAntibody-Dependent EnhancementAntigensBaseBindingBlood Group Antigen SCellsClinical CandidateClinical DevelopmentCountryCovid-19Covid-19 MonitoringCovid-19 PandemicCovid-19 PreventionCovid-19 VaccineCytokineDangerousnessDesignDisease Outbreaks2019-Ncov